From 022c222fdd8958a3e98d79c197c41b38bc0f40d1 Mon Sep 17 00:00:00 2001 From: borja Date: Wed, 30 Oct 2024 14:47:18 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/InCORNTD 2025___Application.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/InCORNTD 2025___Application.md b/pages/InCORNTD 2025___Application.md index bc61445b..c47f7a1a 100644 --- a/pages/InCORNTD 2025___Application.md +++ b/pages/InCORNTD 2025___Application.md @@ -3,5 +3,5 @@ - **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial, although its potential uses go beyond these parasites. The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing better efficacy against more species of helminths. - While the frequently used albendazole 400mg monotherapy + While the frequently used albendazole 400mg monotherapy barely manages to reduce the prevalence of *Trichuris trichiura*, combining it with ivermectin - \ No newline at end of file